| Literature DB >> 23890825 |
Cristian G Bologa1, Oleg Ursu, Tudor I Oprea, Charles E Melançon, George P Tegos.
Abstract
This article highlights current trends and advances in exploiting natural sources for the deployment of novel and potent anti-infective countermeasures. The key challenge is to therapeutically target bacterial pathogens that exhibit a variety of puzzling and evolutionarily complex resistance mechanisms. Special emphasis is given to the strengths, weaknesses, and opportunities in the natural product antibacterial drug discovery arena, and to emerging applications driven by advances in bioinformatics, chemical biology, and synthetic biology in concert with exploiting bacterial phenotypes. These efforts have identified a critical mass of natural product antibacterial lead compounds and discovery technologies with high probability of successful implementation against emerging bacterial pathogens.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23890825 PMCID: PMC3795984 DOI: 10.1016/j.coph.2013.07.002
Source DB: PubMed Journal: Curr Opin Pharmacol ISSN: 1471-4892 Impact factor: 5.547